Provided by Tiger Trade Technology Pte. Ltd.

Prime Medicine, Inc.

2.98
-0.0100-0.33%
Post-market: 3.000.0200+0.67%19:55 EDT
Volume:2.11M
Turnover:6.28M
Market Cap:537.92M
PE:-2.75
High:3.08
Open:3.05
Low:2.92
Close:2.99
52wk High:6.94
52wk Low:2.67
Shares:180.51M
Float Shares:116.00M
Volume Ratio:0.52
T/O Rate:1.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0853
EPS(LYR):-1.3521
ROE:-373.29%
ROA:-46.52%
PB:13.51
PE(LYR):-2.20

Loading ...

Prime Medicine, Inc. Q2 EPS USD -0.24

Reuters
·
Aug 06

Prime Medicine Q2 FY26 Net Loss Narrows to $42.1 Million

Reuters
·
Aug 06

Prime Medicine Q2 EPS $(0.24) Beats $(0.26) Estimate, Sales $1.154M Miss $1.295M Estimate

Benzinga Earnings
·
Aug 06

Press Release: Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
Aug 06

Prime Medicine, Inc. Q2 Income from Operations USD -43.285 Million

THOMSON REUTERS
·
Aug 06

Prime Medicine, Inc: Expects Cash and Investments as of June 30, 2026 Sufficient to Fund Operations into 2027

THOMSON REUTERS
·
Aug 06

Scribe's Genetic Editing Aims to Prevent Heart Attacks

Dow Jones
·
Jul 30

Prime Medicine Says FDA Clears IND for Pm577a in Wilson Disease Trial

Reuters
·
Jul 24

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for Pm577a in H1069q-mutated Wilson Disease

THOMSON REUTERS
·
Jul 24

Prime Medicine, - Phase 1/2 Trial for Pm577a Expected to Start in H2 2026 with Initial Data in 2027

THOMSON REUTERS
·
Jul 24

LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)

TIPRANKS
·
Jul 11

Prime Medicine Down Nearly 14%, on Pace for Largest Percent Decrease Since May 2025

Dow Jones
·
Jul 10

TD Cowen says arbitration decision removes overhang for Prime Medicine’s PM647

TIPRANKS
·
Jul 09

Resolution in favor of Prime has limited impact to Beam, says BofA

TIPRANKS
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Prime Medicine, Inc. (PRME)

TIPRANKS
·
Jul 08

Prime Medicine Posts Corporate Deck Highlighting Prime-editing Platform, Lead Programs in Wilson Disease and AATD

Reuters
·
Jul 08

Prime Medicine Wins Arbitration with Beam over AATD Therapy PM647

Reuters
·
Jul 08

Prime Medicine, - Initial Clinical Data for Pm647 Expected in 2027

THOMSON REUTERS
·
Jul 08

Prime Medicine, - Arbitration Tribunal Confirms Prime Medicine's Right to Develop and Commercialize Pm647 in Aatd

THOMSON REUTERS
·
Jul 08

Prime Medicine, - Owes no Monetary Damages to Beam Therapeutics

THOMSON REUTERS
·
Jul 08